Ascent AeroSystems’ SPIRIT™ Joins Blue UAS Framework as a Cleared Component, Building on Its Status as a Blue UAS-Cleared System 3-09-2025, 06:26

Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma 16-10-2023, 19:21

WillScot Announces Investor Conference Schedule for September 2024 22-08-2024, 03:01